| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.6 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |